US 7,741,461 B2 · Nucleic acid probes and methods for detecting clinically important fungal pathogens

Abstract

The current invention relates to the field of detection and identification of clinically important fungi. More particularly, the present invention relates to species specific probes originating from the Internal Transcribed Spacer (ITS) region of rDNA for the detection of fungal species such as Candida albicans, Candida parapsilosis, Candida tropicalis, Candida kefyr, Candida krusei, Candida glabrata, Candida dubliniensis, Aspergillus flavus, Aspergillus versicolor, Aspergillus nidulans, Aspergillus fumigatus, Cryptococcus neoformans and Pneumocystis carinii in clinical samples, and methods using said probes.

Claims9

Dependent claims

An isolated oligonucleotide molecule consisting of SEQ ID NO:

26, 41, or the RNA equivalents of said SEQ IDs wherein T is replaced by U, or the complements thereof.

Dependencies are inferred from the claim text.

Facts

Application

10/967,254Filed 19 Oct 2004 · division

Priority

EP 9987010928 May 1999

Published

US 2005/0164243 A128 Jul 2005

Granted

22 Jun 2010

Term ends

Not estimatedThe source records don’t support an estimate.

Classification2 codes

C12Q 1/6895
For detection or identification of organisms: for plants, fungi or algae
C12Q
Measuring or testing processes involving enzymes, nucleic acids or microorganisms

Family

Application60/138,621Us provisional application · filed 11 Jun 1999

PCT/EP00/04714Parent of this division · filed 24 May 2000

US 2005/0164243 A1Pre-grant publication · published 28 Jul 2005

Application09/662,462Parent of this division

US 6,858,387 B1Parent of this division

US 7,741,461 B2This patent

From the US filing history. Foreign family members aren’t listed.

Nucleic acid probes and methods for detecting clinically important fungal pathogens

Life of this patent

Nucleic acid probes and methods for detecting clinically important fungal pathogens

Life of this patent

Abstract

Claims9